Good gut treatment is rarely a single pill. It is a sequence: confirm what you’re treating, reduce the overgrowth or remove the trigger, support the motility that keeps the gut clear, and prevent relapse. Done in the wrong order, individual treatments under-perform. Here is how the logic fits together - and where the evidence for it is strong versus thin.
Most evidence-informed gut protocols, whether for SIBO or fungal overgrowth, follow the same three movements:
Where the evidence stands: the eradication step is the best-supported (randomised trials for rifaximin; smaller studies for herbs and elemental diet). The relapse-prevention step rests mostly on small, observational data - the rationale is sound, the trial base is thin. Treat the sequence as a reasonable framework, not a proven algorithm.
Overgrowth is usually a downstream consequence of something else - a sluggish migrating motor complex after food poisoning, acid suppression from long-term PPIs, an anatomical quirk. Clear the organisms without addressing that, and they return. This is why the most durable results come from the unglamorous middle step: fixing function. It is also why relapse is not a sign the diagnosis was wrong.
Safety first, always. Protocols involving prescription medicines - especially off-label use - belong under clinical supervision. Alarm symptoms (weight loss, blood in the stool, difficulty swallowing, persistent vomiting, fever) override any protocol and warrant urgent assessment.
The condition pillars work through these steps in detail for each scenario:
Want a protocol built around your actual test results?
Enquire about a consultation